Skip to main content
Erschienen in: Zeitschrift für Gerontologie und Geriatrie 4/2014

01.06.2014 | Beiträge zum Themenschwerpunkt

Design of pharmaceutical products to meet future patient needs requires modification of current development paradigms and business models

verfasst von: Dr. S. Stegemann, J.-P. Baeyens, R. Becker, M. Maio, M. Bresciani, T. Shreeves, C. Azadi, F. Ecker, M. Gogol

Erschienen in: Zeitschrift für Gerontologie und Geriatrie | Ausgabe 4/2014

Einloggen, um Zugang zu erhalten

Abstract

Drugs represent the most common intervention strategy for managing acute and chronic medical conditions. In light of demographic change and the increasing age of patients, the classic model of drug research and development by the pharmaceutical industry and drug prescription by physicians is reaching its limits. Different stakeholders, e.g. industry, regulatory authorities, health insurance systems, physicians etc., have at least partially differing interests regarding the process of healthcare provision. The primary responsibility for the correct handling of medication and adherence to treatment schedules lies with the recipient of a drug-based therapy, i.e. the patient. It is thus necessary to interactively involve elderly patients, as well as the other stakeholders, in the development of medication and medication application devices, and in clinical trials. This approach will provide the basis for developing a strategy that better meets patients’ needs, thus resulting in improved adherence to treatment schedules and better therapeutic outcomes.
Literatur
1.
Zurück zum Zitat Dohrmann M, Biecheler P, Hosseini M, Nyctellus H (2012) Pharma’s fight for profitability. Lifecycle-based operating models. Roland Berger Strategy Consultants Dohrmann M, Biecheler P, Hosseini M, Nyctellus H (2012) Pharma’s fight for profitability. Lifecycle-based operating models. Roland Berger Strategy Consultants
2.
Zurück zum Zitat Jaruzelski B, Loehr J, Holman R (2011) The Global Innovation 1000. Why culture is the key. Booz&Co Report. http://www.booz.com/media/uploads/BoozCo-Global-Innovation-1000-2011-Culture-Key.pdf Jaruzelski B, Loehr J, Holman R (2011) The Global Innovation 1000. Why culture is the key. Booz&Co Report. http://​www.​booz.​com/​media/​uploads/​BoozCo-Global-Innovation-1000-2011-Culture-Key.​pdf
3.
Zurück zum Zitat Kielstra P (2012) A new vision for old age: Rethinking health policy for Europe’s ageing society. A report from the Economist Intelligence Unit. The Economist Intelligence Unit Limited, London Kielstra P (2012) A new vision for old age: Rethinking health policy for Europe’s ageing society. A report from the Economist Intelligence Unit. The Economist Intelligence Unit Limited, London
4.
Zurück zum Zitat Hughes CM (2004) Medication non-adherence in the elderly: how big is the problem? Drugs Aging 21:793–811CrossRefPubMed Hughes CM (2004) Medication non-adherence in the elderly: how big is the problem? Drugs Aging 21:793–811CrossRefPubMed
5.
Zurück zum Zitat Haynes RB, McDonald H, Garg AX, Montague P (2002) Interventions for helping patients to follow prescriptions for medications. Cochrane Database Syst Rev CD000011 Haynes RB, McDonald H, Garg AX, Montague P (2002) Interventions for helping patients to follow prescriptions for medications. Cochrane Database Syst Rev CD000011
6.
Zurück zum Zitat CapGemini Report (2011) Patient adherence: the next frontier in patient care, Vision & reality 9th edition. http://www.capgemini.com/m/en/tl/Patient_Adherence__The_Next_Frontier_in_Patient_Care.pdf CapGemini Report (2011) Patient adherence: the next frontier in patient care, Vision & reality 9th edition. http://​www.​capgemini.​com/​m/​en/​tl/​Patient_​Adherence_​_​The_​Next_​Frontier_​in_​Patient_​Care.​pdf
7.
Zurück zum Zitat Sabate E (ed) (2003) Adherence to long-term therapies: evidence for action. World Health Organization. http://www.who.int/chronic_conditions/en/adherence_report.pdf Sabate E (ed) (2003) Adherence to long-term therapies: evidence for action. World Health Organization. http://​www.​who.​int/​chronic_​conditions/​en/​adherence_​report.​pdf
8.
Zurück zum Zitat International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (2009) ICH Harmonised—Tripartite Guideline Pharmaceutical Development Q8(R2) http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q8_R1/Step4/Q8_R2_Guideline.pdf International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (2009) ICH Harmonised—Tripartite Guideline Pharmaceutical Development Q8(R2) http://​www.​ich.​org/​fileadmin/​Public_​Web_​Site/​ICH_​Products/​Guidelines/​Quality/​Q8_​R1/​Step4/​Q8_​R2_​Guideline.​pdf
9.
Zurück zum Zitat Atkin PA, Finnegan TP, Ogle SJ, Shenfield GM (1994) Functional ability of patients to manage medication packaging: a survey of geriatric inpatients. Age Ageing 23:113–116CrossRefPubMed Atkin PA, Finnegan TP, Ogle SJ, Shenfield GM (1994) Functional ability of patients to manage medication packaging: a survey of geriatric inpatients. Age Ageing 23:113–116CrossRefPubMed
10.
Zurück zum Zitat Stegemann S, Gosch M, Breitkreutz J (2012) Swallowing dysfunction and dysphagia is an unrecognized challenge for oral drug therapy. Int J Pharm 430:197–206CrossRefPubMed Stegemann S, Gosch M, Breitkreutz J (2012) Swallowing dysfunction and dysphagia is an unrecognized challenge for oral drug therapy. Int J Pharm 430:197–206CrossRefPubMed
11.
Zurück zum Zitat Klaver CC, Wolfs RC, Vingerling JR et al (1998) Age-specific prevalence and causes of blindness and visual impairment in an older population. Arch Ophthalmol 116:653–658CrossRefPubMed Klaver CC, Wolfs RC, Vingerling JR et al (1998) Age-specific prevalence and causes of blindness and visual impairment in an older population. Arch Ophthalmol 116:653–658CrossRefPubMed
12.
Zurück zum Zitat Doyle et al (2012) The European Health literacy survey: Results from Ireland. http://www.healthliteracy.ie/wp-content/uploads/2010/11/EU-Health-Literacy-Survey-Full-Report.pdf Doyle et al (2012) The European Health literacy survey: Results from Ireland. http://​www.​healthliteracy.​ie/​wp-content/​uploads/​2010/​11/​EU-Health-Literacy-Survey-Full-Report.​pdf
13.
Zurück zum Zitat EMA (2008) Commission guideline on the format and content of applications for agreement or modification of a paediatric investigation plan and requests for waivers or deferrals, and concerning the operation of the compliance check, and on criteria for assessing significant studies. Official Journal of the European Union 2008/C 243/01 EMA (2008) Commission guideline on the format and content of applications for agreement or modification of a paediatric investigation plan and requests for waivers or deferrals, and concerning the operation of the compliance check, and on criteria for assessing significant studies. Official Journal of the European Union 2008/C 243/01
14.
Zurück zum Zitat EMA (2013) Concept paper on the need for a reflection paper on quality aspects of medicines for older people EMA/165974/2013. http://www.ema.europa.eu/ema/doc_index.jsp?curl=pages/includes/document/document_detail.jsp?webContentId=WC500141560&mid=0b01ac058009a3dc EMA (2013) Concept paper on the need for a reflection paper on quality aspects of medicines for older people EMA/165974/2013. http://​www.​ema.​europa.​eu/​ema/​doc_​index.​jsp?​curl=​pages/​includes/​document/​document_​detail.​jsp?​webContentId=​WC500141560&​mid=​0b01ac058009a3dc​
15.
Zurück zum Zitat Hanlon JT, Schmader KE, Koronkowski MJ et al (1997) Adverse drug events in high risk older outpatients. J Am Geriatr Soc 45:945–948PubMed Hanlon JT, Schmader KE, Koronkowski MJ et al (1997) Adverse drug events in high risk older outpatients. J Am Geriatr Soc 45:945–948PubMed
16.
Zurück zum Zitat Lindenberger U, Smith J, Mayer KU, Baltes PB (eds) (2010) Die Berliner Alterstudie (BASE), 3rd edn. Akademie Verlag, Berlin Lindenberger U, Smith J, Mayer KU, Baltes PB (eds) (2010) Die Berliner Alterstudie (BASE), 3rd edn. Akademie Verlag, Berlin
17.
Zurück zum Zitat Stegemann S, Ecker F, Maio M et al (2010) Geriatric drug therapy: neglecting the inevitable majority. Ageing Res Rev 9:384–398CrossRefPubMed Stegemann S, Ecker F, Maio M et al (2010) Geriatric drug therapy: neglecting the inevitable majority. Ageing Res Rev 9:384–398CrossRefPubMed
18.
Zurück zum Zitat Cerreta F, Eichler HG, Rasi G (2012) Drug policy for an aging population—the European Medicines Agency’s geriatric medicine strategy. N Engl J Med 367:1972–1974CrossRefPubMed Cerreta F, Eichler HG, Rasi G (2012) Drug policy for an aging population—the European Medicines Agency’s geriatric medicine strategy. N Engl J Med 367:1972–1974CrossRefPubMed
19.
Zurück zum Zitat Strachan I, Greener M (2005) Medication-related swallowing difficulties may be more common than we realize. Pharmacy Practice 15(10):411–414 Strachan I, Greener M (2005) Medication-related swallowing difficulties may be more common than we realize. Pharmacy Practice 15(10):411–414
Metadaten
Titel
Design of pharmaceutical products to meet future patient needs requires modification of current development paradigms and business models
verfasst von
Dr. S. Stegemann
J.-P. Baeyens
R. Becker
M. Maio
M. Bresciani
T. Shreeves
C. Azadi
F. Ecker
M. Gogol
Publikationsdatum
01.06.2014
Verlag
Steinkopff-Verlag
Erschienen in
Zeitschrift für Gerontologie und Geriatrie / Ausgabe 4/2014
Print ISSN: 0948-6704
Elektronische ISSN: 1435-1269
DOI
https://doi.org/10.1007/s00391-014-0647-4

Weitere Artikel der Ausgabe 4/2014

Zeitschrift für Gerontologie und Geriatrie 4/2014 Zur Ausgabe